Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 151 to 175 of 2003

TitleReference numberPublishedLast updated
Artificial intelligence (AI) technologies to help detect fractures on X-rays in urgent care: early value assessmentHTE20
Digitally enabled therapies for adults with depression: early value assessmentHTE8
Overweight and obesity managementNG246
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adultsIPG799
Tebentafusp for treating advanced uveal melanomaTA1027
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasiaIPG798
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndromeDG62
MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson'sIPG796
MRI-guided focused ultrasound subthalamotomy for treating Parkinson'sIPG797
Ublituximab for treating relapsing multiple sclerosisTA1025
Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implantIPG795
Urinary tract infection (recurrent): antimicrobial prescribingNG112
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1023
Toripalimab with chemotherapy for untreated advanced oesophageal squamous cell cancer (terminated appraisal)TA1024
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA1021
Bevacizumab gamma for treating wet age-related macular degenerationTA1022
Eplontersen for treating hereditary transthyretin-related amyloidosisTA1020
Asthma pathway (BTS, NICE, SIGN)NG244
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)NG245
Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overTA1019
Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1017
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA1018
Endoscopic bipolar radiofrequency ablation for malignant biliary obstructionIPG794
Elafibranor for previously treated primary biliary cholangitisTA1016
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1015

Results per page

  1. 10
  2. 25
  3. 50
  4. All